XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2023
Commitments And Contingencies Disclosure [Abstract]  
Schedule of Lease Term and Discount Rate

Financing liability information was as follows:

 

 

March 31, 2023

 

 

December 31, 2022

 

Weighted average remaining lease term (in years)

 

 

18.6

 

 

 

18.8

 

Weighted average discount rate

 

 

9.0

%

 

 

9.0

%

Lease information was as follows (in thousands):

 

 

March 31, 2023

 

 

December 31, 2022

 

Operating lease right-of-use assets(1)

 

$

5,648

 

 

$

6,714

 

 

 

 

 

 

 

 

Operating lease liability-current(2)

 

$

851

 

 

$

1,304

 

Operating lease liability-long-term

 

 

4,879

 

 

 

5,343

 

Total

 

$

5,730

 

 

$

6,647

 

 

 

 

 

 

 

 

Weighted average remaining lease term (in years)

 

 

4.4

 

 

 

4.6

 

Weighted average discount rate

 

 

7.3

%

 

 

7.3

%

_________________________

(1)
Operating right-of-use assets related to vehicles, offices and the manufacturing facility are included in other assets in the condensed consolidated balance sheets.
(2)
Operating lease liability – current are included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.
Summary of Lease Information

 

 

Three Months
Ended March 31,

 

 

 

2023

 

 

2022

 

Interest expense on financing liability

 

$

2,424

 

 

$

2,371

 

 

 

 

Three Months
Ended March 31,

 

 

 

2023

 

 

2022

 

Operating lease costs

 

$

422

 

 

$

288

 

Variable lease costs

 

 

36

 

 

 

86

 

Cash paid

 

 

323

 

 

 

442

 

Summary of Remaining Financing Liability Payments

The Company's remaining financing liability payments were as follows (in thousands):

 

 

March 31, 2023

 

2023

 

$

7,340

 

2024

 

 

10,018

 

2025

 

 

10,269

 

2026

 

 

10,533

 

2027

 

 

10,849

 

Thereafter

 

 

188,453

 

Total

 

 

237,462

 

Interest payments

 

 

(130,563

)

Debt issuance costs

 

 

(2,832

)

Total financing liability

 

$

104,067

 

Remaining Purchase Requirements

In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. The Company's remaining purchase commitments were as follows (€ in millions):

 

 

March 31, 2023

 

2023

 

 

6.8

 

2024

 

 

14.6

 

2025

 

 

15.5

 

2026

 

 

19.4

 

2027

 

 

9.2

 

Schedule of Future Minimum Office And Vehicle Lease Payments

The Company's future minimum office and vehicle lease payments were as follows (in thousands):

 

 

March 31, 2023

 

2023

 

$

662

 

2024

 

 

1,496

 

2025

 

 

1,861

 

2026

 

 

1,140

 

2027

 

 

1,072

 

Thereafter

 

 

643

 

Total

 

 

6,874

 

Interest expense

 

 

(1,144

)

Total operating lease liability

 

$

5,730